1. Home
  2. BDSX vs EVM Comparison

BDSX vs EVM Comparison

Compare BDSX & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • EVM
  • Stock Information
  • Founded
  • BDSX 2005
  • EVM 2002
  • Country
  • BDSX United States
  • EVM United States
  • Employees
  • BDSX N/A
  • EVM N/A
  • Industry
  • BDSX Precision Instruments
  • EVM Finance/Investors Services
  • Sector
  • BDSX Health Care
  • EVM Finance
  • Exchange
  • BDSX Nasdaq
  • EVM Nasdaq
  • Market Cap
  • BDSX 215.3M
  • EVM 228.0M
  • IPO Year
  • BDSX 2020
  • EVM N/A
  • Fundamental
  • Price
  • BDSX $1.48
  • EVM $9.25
  • Analyst Decision
  • BDSX Strong Buy
  • EVM
  • Analyst Count
  • BDSX 4
  • EVM 0
  • Target Price
  • BDSX $3.08
  • EVM N/A
  • AVG Volume (30 Days)
  • BDSX 257.7K
  • EVM 55.8K
  • Earning Date
  • BDSX 11-01-2024
  • EVM 01-01-0001
  • Dividend Yield
  • BDSX N/A
  • EVM 4.01%
  • EPS Growth
  • BDSX N/A
  • EVM N/A
  • EPS
  • BDSX N/A
  • EVM 0.20
  • Revenue
  • BDSX $65,562,000.00
  • EVM N/A
  • Revenue This Year
  • BDSX $46.97
  • EVM N/A
  • Revenue Next Year
  • BDSX $30.43
  • EVM N/A
  • P/E Ratio
  • BDSX N/A
  • EVM $47.61
  • Revenue Growth
  • BDSX 48.92
  • EVM N/A
  • 52 Week Low
  • BDSX $1.11
  • EVM $7.67
  • 52 Week High
  • BDSX $2.21
  • EVM $9.59
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 58.19
  • EVM 40.00
  • Support Level
  • BDSX $1.31
  • EVM $9.11
  • Resistance Level
  • BDSX $1.61
  • EVM $9.27
  • Average True Range (ATR)
  • BDSX 0.09
  • EVM 0.10
  • MACD
  • BDSX 0.02
  • EVM -0.02
  • Stochastic Oscillator
  • BDSX 70.27
  • EVM 24.07

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value

Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income, and alternative strategies to institutional investors, both in the United States and internationally.

Share on Social Networks: